Dr. Donovan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 South Huntington Avenue
Boston, MA 02130Phone+1 617-323-7700
Education & Training
- Brigham and Women's HospitalFellowship, Gastroenterology, 1989 - 1990
- Brigham and Women's HospitalResidency, Internal Medicine, 1984 - 1987
- Harvard Medical SchoolClass of 1984
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 16 citationsSpread monomolecular films of monohydroxy bile acids and their salts: influence of hydroxyl position, bulk pH, and association with phosphatidylcholine.Monika R. Leonard, Melissa A. Bogle, Martin C. Carey, Joanne M. Donovan
Biochemistry. 2000-12-01 - 120 citationsMipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, pl...Maartje E. Visser, Gilbert Wagener, Brenda F. Baker, Richard S. Geary, Joanne M. Donovan
European Heart Journal. 2012-05-01 - 218 citationsApolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia Results of a Randomized, Double-Blind, Placebo-Controlled Trial to ...Evan A. Stein, Robert Dufour, Claude Gagné, Daniel Gaudet, Cara East
Circulation. 2012-11-06
Press Mentions
- Edgewise Therapeutics Announces Initiation of LYNX Phase 2 Clinical Trial of EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (DMD)October 28th, 2022
- EDG-5506 Shows Promise at Reducing Becker MD Muscle DamageOctober 20th, 2022
- EDG-5506 Shows Promise at Reducing Becker MD Muscle DamageOctober 20th, 2022
- Join now to see all
Grant Support
- Pilot Study--Mechanisms Of Cytoprotection By Hydrophilic Bile SaltsNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: